期刊文献+

肾小球疾病免疫抑制剂治疗的新方向——多靶点免疫抑制治疗 被引量:35

下载PDF
导出
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 2007年第1期3-4,共2页 Chinese Journal of Nephrology,Dialysis & Transplantation
  • 相关文献

参考文献17

  • 1Luetscher JA Jr,Deming QB.Treatment of nephrosis with cortisone.J Clin Invest,1950,29(12):1576-1587.
  • 2Coldbeck JH.Experience with alkylating agents in the treatment of children with the nephritic syndrome.Med J Aust,1963,41:987-989.
  • 3Verzetti G,Perpignano G,Busilacchi M,et al.Chlorambucil in the treatment of the nephrotic syndrome.Minerva Nefrol,1966,13(3):87-90.
  • 4Castellani A,Romagnoli GF,Rizzo A,et al.Preliminary report on the effects of immunosuppressive therapy with azathioprine in glomerulonephritis.Minerva Nefrol,1968,15(4):219-235.
  • 5Calne RY,White DJ,Thiru S,et al.Cyclosporin A in patients receiving renal allografts from cadaver donors.Lancet,1978,2(8104-5):1323-1327.
  • 6Inou T,Kusaba R,Takahashi I,et al.Clinical trial of Bredinin in renal transplantation.Transplant Proc,1980,12(3):526-528.
  • 7胡伟新,黎磊石.重症狼疮性肾炎合并感染和肾衰应用霉酚酸酯治疗[J].肾脏病与透析肾移植杂志,1997,6(5):491-497. 被引量:30
  • 8陈强,刘志红,胡伟新,姚小丹,陈惠萍,陈欣,程震,张波,曾彩虹,黎磊石.普乐可复治疗Ⅳ型狼疮性肾炎的前瞻性临床研究[J].肾脏病与透析肾移植杂志,2002,11(4):301-307. 被引量:33
  • 9Hu W,Liu Z,Chen H,et al.Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.Chin Med J(Engl),2002,115(5):705-709.
  • 10Seheinman RI,Cogswell PC,Lofquist AK et al.Role of transcriptional activation of IκBα in mediation of immuno-suppression by glucocorticoids.Science,1995,270-283.

二级参考文献46

  • 1沈克勤,黎磊石,刘志红,张景红.环孢霉素A治疗狼疮性肾炎的临床研究[J].医学研究生学报,1991,4(2):95-98. 被引量:3
  • 2刘春蓓,胡伟新,谢红浪,章海涛,陈惠萍,曾彩虹,刘志红,黎磊石.霉酚酸酯与环磷酰胺治疗Ⅳ型伴Ⅴ型狼疮性肾炎的疗效比较[J].肾脏病与透析肾移植杂志,2006,15(1):1-6. 被引量:34
  • 3胡伟新,刘春蓓,孙海鸥,刘正钊,谢红浪,章海涛,陈惠萍,曾彩虹,刘志红,黎磊石.1352例狼疮性肾炎的临床与免疫学特征[J].肾脏病与透析肾移植杂志,2006,15(5):401-408. 被引量:48
  • 4Churg J,Sobin LH.Lupus nephritis,in renal disease.Classification and atlas of glomerular disease.New York,Igaku-Shoin,1982,127-149.
  • 5Schwartz MM,Lan SP,Bonsib SM,et al.Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis.Am J Kidney Dis,1989,13:273 -283.
  • 6Sloan RP,Schwartz MM,Korbet,SM,et al.Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis.J Am Soc Nephrol,1996,7:299-305.
  • 7Weening JJ,D'Agati VD,Schwartz MM,et al.The classification of glomerulonephritis in systemic lupus erythematosus revisited.Kidney Int,2004,65:521-530.
  • 8Hu W,Liu Z,Chen H,et al.Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.Chin Med J (Engl),2002,115:705 -709.
  • 9Chan TM,Tse KC,Tang CS,et al.Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.J Am Soc Nephrol,2005,16:1076-1084.
  • 10Ginzler EM,Dooley MA,Aranow C,et al.Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.N Engl J Med,2005,353:2219 -2228.

共引文献93

同被引文献326

引证文献35

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部